{"id":"https://openalex.org/W7116844522","doi":"https://doi.org/10.1208/s12248-025-01186-8","title":"Revisiting the Anti-Drug Antibody Assay Drug Tolerance of a Commercial Biological Product","display_name":"Revisiting the Anti-Drug Antibody Assay Drug Tolerance of a Commercial Biological Product","publication_year":2025,"publication_date":"2025-12-23","ids":{"openalex":"https://openalex.org/W7116844522","doi":"https://doi.org/10.1208/s12248-025-01186-8","pmid":"https://pubmed.ncbi.nlm.nih.gov/41436902"},"language":"en","primary_location":{"id":"doi:10.1208/s12248-025-01186-8","doi":"https://doi.org/10.1208/s12248-025-01186-8","is_oa":true,"landing_page_url":"https://doi.org/10.1208/s12248-025-01186-8","pdf_url":"https://link.springer.com/content/pdf/10.1208/s12248-025-01186-8.pdf","source":{"id":"https://openalex.org/S74983066","display_name":"The AAPS Journal","issn_l":"1550-7416","issn":["1550-7416"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The AAPS Journal","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1208/s12248-025-01186-8.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018286674","display_name":"James A. Zanghi","orcid":"https://orcid.org/0000-0002-7457-6411","observed_orcids":["https://orcid.org/0000-0002-7457-6411"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":null,"type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":[],"is_corresponding":true,"raw_author_name":"James Zanghi","raw_affiliation_strings":["BioAnalytical Sciences, Building 47, 660 E Grand Ave, South San Francisco, Genentech, California, 94080, USA. zanghij@gene.com"],"raw_orcid":"https://orcid.org/0000-0002-7457-6411","affiliations":[{"raw_affiliation_string":"BioAnalytical Sciences, Building 47, 660 E Grand Ave, South San Francisco, Genentech, California, 94080, USA. zanghij@gene.com","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5133689124","display_name":"Nancy Yu","orcid":"https://orcid.org/0009-0009-1966-8231","observed_orcids":["https://orcid.org/0009-0009-1966-8231"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":null,"type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":[],"is_corresponding":false,"raw_author_name":"Nancy Yu","raw_affiliation_strings":["BioAnalytical Sciences, Building 47, 660 E Grand Ave, South San Francisco, Genentech, California, 94080, USA"],"raw_orcid":"https://orcid.org/0009-0009-1966-8231","affiliations":[{"raw_affiliation_string":"BioAnalytical Sciences, Building 47, 660 E Grand Ave, South San Francisco, Genentech, California, 94080, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5133714397","display_name":"Benjamin T. Andrews","orcid":"https://orcid.org/0009-0000-7947-3537","observed_orcids":["https://orcid.org/0009-0000-7947-3537"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":null,"type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":[],"is_corresponding":false,"raw_author_name":"Benjamin T. Andrews","raw_affiliation_strings":["BioAnalytical Sciences, Building 47, 660 E Grand Ave, South San Francisco, Genentech, California, 94080, USA"],"raw_orcid":"https://orcid.org/0009-0000-7947-3537","affiliations":[{"raw_affiliation_string":"BioAnalytical Sciences, Building 47, 660 E Grand Ave, South San Francisco, Genentech, California, 94080, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089235307","display_name":"Phyllis Chan","orcid":"https://orcid.org/0000-0003-1509-1526","observed_orcids":["https://orcid.org/0000-0003-1509-1526"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":null,"type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Phyllis Chan","raw_affiliation_strings":["Clinical Pharmacology, Genentech, South San Francisco, California, USA"],"raw_orcid":"https://orcid.org/0000-0003-1509-1526","affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Genentech, South San Francisco, California, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104577149","display_name":"Maxime Usdin","orcid":"https://orcid.org/0009-0008-9271-0267","observed_orcids":["https://orcid.org/0009-0008-9271-0267"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":null,"type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":[],"is_corresponding":false,"raw_author_name":"Maxime Usdin","raw_affiliation_strings":["gRED Computational Sciences, Genentech, South San Francisco, California, USA"],"raw_orcid":"https://orcid.org/0009-0008-9271-0267","affiliations":[{"raw_affiliation_string":"gRED Computational Sciences, Genentech, South San Francisco, California, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082749535","display_name":"Cecilia Chiu","orcid":"https://orcid.org/0000-0001-8797-9984","observed_orcids":["https://orcid.org/0000-0001-8797-9984"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":null,"type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":[],"is_corresponding":false,"raw_author_name":"Cecilia Chiu","raw_affiliation_strings":["Antibody Engineering, Genentech, South San Francisco, California, USA"],"raw_orcid":"https://orcid.org/0000-0001-8797-9984","affiliations":[{"raw_affiliation_string":"Antibody Engineering, Genentech, South San Francisco, California, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5121061367","display_name":"WeiYu Lin","orcid":"https://orcid.org/0000-0003-4363-7848","observed_orcids":["https://orcid.org/0000-0003-4363-7848"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":null,"type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":[],"is_corresponding":false,"raw_author_name":"WeiYu Lin","raw_affiliation_strings":["Antibody Engineering, Genentech, South San Francisco, California, USA"],"raw_orcid":"https://orcid.org/0000-0003-4363-7848","affiliations":[{"raw_affiliation_string":"Antibody Engineering, Genentech, South San Francisco, California, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000723341","display_name":"Alyse Lin","orcid":"https://orcid.org/0000-0003-1730-3713","observed_orcids":["https://orcid.org/0000-0003-1730-3713"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":null,"type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alyse Lin","raw_affiliation_strings":["Clinical Pharmacology, Genentech, South San Francisco, California, USA"],"raw_orcid":"https://orcid.org/0000-0003-1730-3713","affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Genentech, South San Francisco, California, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5121066152","display_name":"Yuan Song","orcid":"https://orcid.org/0009-0004-5840-3133","observed_orcids":["https://orcid.org/0009-0004-5840-3133"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":null,"type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":[],"is_corresponding":false,"raw_author_name":"Yuan Song","raw_affiliation_strings":["BioAnalytical Sciences, Building 47, 660 E Grand Ave, South San Francisco, Genentech, California, 94080, USA"],"raw_orcid":"https://orcid.org/0009-0004-5840-3133","affiliations":[{"raw_affiliation_string":"BioAnalytical Sciences, Building 47, 660 E Grand Ave, South San Francisco, Genentech, California, 94080, USA","institution_ids":["https://openalex.org/I183934855"]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5018286674"],"corresponding_institution_ids":["https://openalex.org/I183934855"],"apc_list":{"value":5090,"currency":"USD","value_usd":5090},"apc_paid":{"value":5090,"currency":"USD","value_usd":5090},"fwci":0.6014,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.68827487,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":97},"biblio":{"volume":"28","issue":"1","first_page":"41","last_page":"41"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-tolerance","display_name":"drug tolerance","score":0.7960000038146973},{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":0.9929999709129333},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.7170000076293945},{"id":"https://openalex.org/keywords/subcutaneous-administration","display_name":"subcutaneous administration","score":0.9639999866485596},{"id":"https://openalex.org/keywords/population-pharmacokinetic-model","display_name":"population pharmacokinetic model","score":0.8309999704360962},{"id":"https://openalex.org/keywords/binding-kinetics","display_name":"binding kinetics","score":0.722000002861023},{"id":"https://openalex.org/keywords/assay-sensitivity","display_name":"assay sensitivity","score":0.492000013589859},{"id":"https://openalex.org/keywords/drug-exposure","display_name":"drug exposure","score":0.4259999990463257}],"concepts":[{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.6010000109672546},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5307000279426575},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5234000086784363},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46630001068115234},{"id":"https://openalex.org/C137535248","wikidata":"https://www.wikidata.org/wiki/Q4914691","display_name":"Bioanalysis","level":2,"score":0.45410001277923584},{"id":"https://openalex.org/C2780449318","wikidata":"https://www.wikidata.org/wiki/Q18344773","display_name":"Critical quality attributes","level":3,"score":0.4334999918937683},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4131999909877777},{"id":"https://openalex.org/C2779652045","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Pharmaceutical industry","level":2,"score":0.4036000072956085},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.39250001311302185},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.3856000006198883},{"id":"https://openalex.org/C2910466267","wikidata":"https://www.wikidata.org/wiki/Q718753","display_name":"Drug-drug interaction","level":3,"score":0.3840000033378601},{"id":"https://openalex.org/C2779985140","wikidata":"https://www.wikidata.org/wiki/Q1425425","display_name":"Drug tolerance","level":2,"score":0.366100013256073},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.36230000853538513},{"id":"https://openalex.org/C3018890749","wikidata":"https://www.wikidata.org/wiki/Q204711","display_name":"Food and drug administration","level":2,"score":0.3582000136375427},{"id":"https://openalex.org/C2779535233","wikidata":"https://www.wikidata.org/wiki/Q12140","display_name":"Pharmaceutical drug","level":3,"score":0.3580999970436096},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.35409998893737793},{"id":"https://openalex.org/C2992293740","wikidata":"https://www.wikidata.org/wiki/Q4781752","display_name":"Drug approval","level":3,"score":0.3447999954223633},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.319599986076355},{"id":"https://openalex.org/C90673727","wikidata":"https://www.wikidata.org/wiki/Q901718","display_name":"Product (mathematics)","level":2,"score":0.3111000061035156},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.28029999136924744},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.2793000042438507},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.27619999647140503},{"id":"https://openalex.org/C2780367336","wikidata":"https://www.wikidata.org/wiki/Q4808618","display_name":"Assay sensitivity","level":3,"score":0.2741999924182892},{"id":"https://openalex.org/C2779709869","wikidata":"https://www.wikidata.org/wiki/Q1292017","display_name":"Good manufacturing practice","level":3,"score":0.27230000495910645},{"id":"https://openalex.org/C141341695","wikidata":"https://www.wikidata.org/wiki/Q2368661","display_name":"Surrogate endpoint","level":2,"score":0.2680000066757202},{"id":"https://openalex.org/C2992053201","wikidata":"https://www.wikidata.org/wiki/Q2585693","display_name":"Clinical efficacy","level":2,"score":0.26589998602867126},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.2653000056743622},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2619999945163727},{"id":"https://openalex.org/C42404028","wikidata":"https://www.wikidata.org/wiki/Q864940","display_name":"Bioequivalence","level":3,"score":0.258899986743927}],"mesh":[{"descriptor_ui":"D000888","descriptor_name":"Antibodies, Anti-Idiotypic","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000888","descriptor_name":"Antibodies, Anti-Idiotypic","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000888","descriptor_name":"Antibodies, Anti-Idiotypic","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000888","descriptor_name":"Antibodies, Anti-Idiotypic","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000888","descriptor_name":"Antibodies, Anti-Idiotypic","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000888","descriptor_name":"Antibodies, Anti-Idiotypic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000888","descriptor_name":"Antibodies, Anti-Idiotypic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000888","descriptor_name":"Antibodies, Anti-Idiotypic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000888","descriptor_name":"Antibodies, Anti-Idiotypic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000888","descriptor_name":"Antibodies, Anti-Idiotypic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D004361","descriptor_name":"Drug Tolerance","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D004361","descriptor_name":"Drug Tolerance","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D004361","descriptor_name":"Drug Tolerance","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D004361","descriptor_name":"Drug Tolerance","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D004361","descriptor_name":"Drug Tolerance","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1208/s12248-025-01186-8","doi":"https://doi.org/10.1208/s12248-025-01186-8","is_oa":true,"landing_page_url":"https://doi.org/10.1208/s12248-025-01186-8","pdf_url":"https://link.springer.com/content/pdf/10.1208/s12248-025-01186-8.pdf","source":{"id":"https://openalex.org/S74983066","display_name":"The AAPS Journal","issn_l":"1550-7416","issn":["1550-7416"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The AAPS Journal","raw_type":"journal-article"},{"id":"pmid:41436902","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41436902","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The AAPS journal","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1208/s12248-025-01186-8","doi":"https://doi.org/10.1208/s12248-025-01186-8","is_oa":true,"landing_page_url":"https://doi.org/10.1208/s12248-025-01186-8","pdf_url":"https://link.springer.com/content/pdf/10.1208/s12248-025-01186-8.pdf","source":{"id":"https://openalex.org/S74983066","display_name":"The AAPS Journal","issn_l":"1550-7416","issn":["1550-7416"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The AAPS Journal","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7116844522.pdf","grobid_xml":"https://content.openalex.org/works/W7116844522.grobid-xml"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W1971644921","https://openalex.org/W2050818535","https://openalex.org/W2064771907","https://openalex.org/W2069506532","https://openalex.org/W2462341035","https://openalex.org/W2564934728","https://openalex.org/W2888284775","https://openalex.org/W2973118248","https://openalex.org/W3118158618","https://openalex.org/W3140514993","https://openalex.org/W3195137671","https://openalex.org/W3215384357","https://openalex.org/W4220802570","https://openalex.org/W4311278573","https://openalex.org/W4367042805","https://openalex.org/W4379055533","https://openalex.org/W4392640505","https://openalex.org/W4396768728","https://openalex.org/W4400644922","https://openalex.org/W4401333643","https://openalex.org/W4403539800","https://openalex.org/W4407085790","https://openalex.org/W4407177802","https://openalex.org/W4411246452"],"related_works":[],"abstract_inverted_index":{"Drug":[0],"tolerance":[1],"(DT)":[2],"is":[3],"a":[4,18,22,43,72,111,197],"critical":[5],"attribute":[6],"of":[7,30,46,90,134,159,169,176,188],"anti-drug":[8],"antibody":[9,76],"(ADA)":[10],"assays":[11],"for":[12,86],"assessing":[13],"clinical":[14,68,167],"immunogenicity.":[15],"We":[16,109,153],"present":[17],"unique":[19],"situation":[20],"where":[21],"previously":[23],"approved":[24],"commercial":[25],"product,":[26],"atezolizumab,":[27],"required":[28],"re-assessment":[29],"the":[31,60,81,87,132,156,166,174,186],"assay":[32,82,191],"DT":[33,85,113,144,172],"to":[34,120],"meet":[35],"an":[36],"increased":[37],"drug":[38],"exposure":[39],"demand":[40],"arising":[41],"from":[42],"new":[44,73,88],"route":[45,89],"administration":[47,104],"(subcutaneous)":[48],"and":[49,105,139,165,179],"align":[50],"with":[51,102],"updated":[52],"health":[53],"authority":[54],"(HA)":[55],"regulations.":[56],"Rather":[57],"than":[58],"redevelop":[59],"existing":[61],"ADA":[62,123,161],"assay,":[63],"which":[64],"could":[65],"disrupt":[66],"ongoing":[67],"trials,":[69],"we":[70],"identified":[71],"anti-idiotype":[74],"(anti-ID)":[75],"surrogate":[77,137,160],"that":[78,80,141],"demonstrated":[79],"maintained":[83],"adequate":[84,122],"administration.":[91],"This":[92,128,182],"streamlined":[93],"approach":[94],"addressed":[95],"concerns":[96],"regarding":[97],"higher":[98],"serum":[99],"trough":[100],"concentrations":[101],"subcutaneous":[103],"stricter":[106],"sensitivity":[107],"expectations.":[108],"established":[110],"target":[112],"concentration":[114],"based":[115],"on":[116],"population":[117],"pharmacokinetic":[118],"modeling":[119],"ensure":[121],"characterization":[124],"at":[125],"steady":[126],"state.":[127],"case":[129],"study":[130],"highlights":[131],"value":[133],"having":[135],"alternative":[136],"ADAs":[138],"demonstrates":[140],"achieving":[142,170],"stringent":[143],"requirements":[145],"can":[146],"be":[147],"accomplished":[148],"without":[149],"extensive":[150],"method":[151],"redevelopment.":[152],"also":[154,184],"introduce":[155],"broader":[157],"implications":[158],"selection,":[162],"binding":[163],"kinetics,":[164],"relevance":[168],"high":[171],"in":[173],"context":[175],"atezolizumab's":[177],"efficacy":[178],"safety":[180],"profile.":[181],"work":[183],"emphasizes":[185],"importance":[187],"considering":[189],"bioanalytical":[190],"characteristics,":[192],"such":[193],"as":[194],"DT,":[195],"throughout":[196],"product's":[198],"lifecycle.":[199]},"counts_by_year":[{"year":2026,"cited_by_count":2}],"updated_date":"2026-10-10T09:11:00.788812","created_date":"2025-12-23T00:00:00"}